共 50 条
- [31] Identification of Biomarkers and Mechanistic Insight for Upadacitinib in Crohn's Disease: Serum Inflammatory Mediator Analysis From the Phase 2b CELEST StudyAMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S471 - S472Severine, VermeireGuay, HeathVerstockt, BramHong, FengLee, Wan-JuCataldi, FabioLacerda, AnaDanese, Silvio
- [32] DELAYED CLINICAL RESPONSE IN PATIENTS WITH CROHN'S DISEASE RECEIVING UPADACITINIB THERAPYGASTROENTEROLOGY, 2023, 164 (06) : S1085 - S1086D'Haens, GeertSeidelin, Jakob B.Lugering, AndreasTorres, Esther A.Fleisher, MarkDryden, Gerald W.Lacerda, Ana P.Dubcenco, ElenaMarced, ElenaO'Brien, DanielFeng, TianLiu, JianzhongJuillerat, Pascal
- [33] Endoscopic and clinical outcomes of upadacitinib in patients with moderately to severely active Crohn's disease by number and type of prior biologicsJOURNAL OF CROHNS & COLITIS, 2023, 17 : I20 - I22Peyrin-Biroulet, L.Parkes, G.Rodriguez, C.Siffledeen, J.Wright, J.Broide, E.Ford, S.Lacerda, A. P.Oomen, J.Garrison, A.Berg, S.Rubin, D. T.
- [34] Changes in Simplified Endoscopic Score for Crohn's disease (SES-CD) during a 16-week induction treatment with upadacitinib: analysis of the randomised controlled CELEST studyJOURNAL OF CROHNS & COLITIS, 2019, 13 : S294 - S295Feagan, B.Sandborn, W.Schreiber, S.Huang, B.Alperovich, G.Pangan, A.Lacerda, A.D'Haens, G.
- [35] ENDOSCOPIC AND CLINICAL OUTCOMES OF UPADACITINIB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE BY NUMBER AND TYPE OF PRIOR BIOLOGICSGASTROENTEROLOGY, 2023, 164 (06) : S1094 - S1095Peyrin-Biroulet, LaurentParkes, Gareth C.Gutierrez, Cristina RodriguezSiffledeen, JesseWright, John P.Broide, EfratFord, SharanyaLacerda, Ana P.Oomen, JessicaGarrison, AndrewBerg, SofieRubin, David T.
- [36] Induction of Endoscopic Response, Remission, and Ulcer-Free Endoscopy With Upadacitinib Is Associated With Improved Clinical Outcomes and Quality of Life in Patients With Crohn's DiseaseINFLAMMATORY BOWEL DISEASES, 2024, 31 (02) : 394 - 403Panes, JulianLouis, EdouardBossuyt, PeterJoshi, NamitaLee, Wan-JuLacerda, Ana P.Kligys, KristinaXuan, SiShukla, NidhiLoftus Jr, Edward, V
- [37] Steroid-Free Remission and Fistula Closure in Adalimumab-Treated Patients with Moderate to Severe Crohn's Disease: the Access TrialGASTROENTEROLOGY, 2009, 136 (05) : A653 - A653Panaccione, RemoLoftus, Edward V.Binion, David C.McHugh, KevinChen, NaijunGuerette, BenoitChao, JingdongMulani, Parvez
- [38] Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX TrialCLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (09) : 2074 - 2082Laharie, DavidD'Haens, GeertNachury, MariaLambrecht, GuyBossuyt, PeterBouhnik, YoramLouis, Edouardvan der Woude, Christien JannekeBuisson, AnthonyVan Hootegem, PhilippeAllez, MatthieuFilippi, JeromeBrixi, HediaGilletta, CyriellePicon, LaurenceBaert, FilipVermeire, SeverineDuveau, NicolasPeyrin-Biroulet, Laurent
- [39] Exposure-Response Analyses for Upadacitinib Efficacy and Safety in the Crohn's Disease CELEST Study and Bridging to the Extended-Release FormulationCLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (03) : 639 - 649Mohamed, Mohamed-Eslam F.Kluender, BenLacerda, Ana P.Othman, Ahmed A.
- [40] CHANGES IN SIMPLIFIED ENDOSCOPIC SCORE FOR CROHN'S DISEASE (SES-CD) DURING A 16-WEEK INDUCTION TREATMENT WITH UPADACITINIB: ANALYSIS OF THE RANDOMISED CONTROLLED CELEST STUDYGASTROENTEROLOGY, 2019, 156 (06) : S1103 - S1103Feagan, Brian G.Sandborn, William J.Schreiber, StefanHuang, BidanAlperovich, GabrielaPangan, Aileen L.Lacerda, Ana P.D'Haens, Geert R.